Nagler A, Labopin M, Arat M, Remenyi P, et al. Posttransplant cyclophosphamide-based anti-graft-vs-host disease prophylaxis in patients with acute lymphoblastic leukemia treated in complete remission with allogeneic hematopoietic cell transplantation from human leukocyte antigen-mismatched unrelat Cancer 2022 Sep 15. doi: 10.1002/cncr.34452.
PMID: 36110063